NEPH
Price
$4.28
Change
+$0.45 (+11.75%)
Updated
Sep 8, 01:04 PM (EDT)
Capitalization
40.6M
59 days until earnings call
POCI
Price
$4.59
Change
+$0.12 (+2.68%)
Updated
Sep 8, 10:30 AM (EDT)
Capitalization
34.31M
Interact to see
Advertisement

NEPH vs POCI

Header iconNEPH vs POCI Comparison
Open Charts NEPH vs POCIBanner chart's image
Nephros
Price$4.28
Change+$0.45 (+11.75%)
Volume$200
Capitalization40.6M
Precision Optics
Price$4.59
Change+$0.12 (+2.68%)
VolumeN/A
Capitalization34.31M
NEPH vs POCI Comparison Chart in %
Loading...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEPH vs. POCI commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEPH is a StrongBuy and POCI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (NEPH: $3.83 vs. POCI: $4.47)
Brand notoriety: NEPH and POCI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NEPH: 37% vs. POCI: 271%
Market capitalization -- NEPH: $40.6M vs. POCI: $34.31M
NEPH [@Pharmaceuticals: Other] is valued at $40.6M. POCI’s [@Pharmaceuticals: Other] market capitalization is $34.31M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEPH’s FA Score shows that 0 FA rating(s) are green whilePOCI’s FA Score has 1 green FA rating(s).

  • NEPH’s FA Score: 0 green, 5 red.
  • POCI’s FA Score: 1 green, 4 red.
According to our system of comparison, NEPH is a better buy in the long-term than POCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEPH’s TA Score shows that 5 TA indicator(s) are bullish while POCI’s TA Score has 3 bullish TA indicator(s).

  • NEPH’s TA Score: 5 bullish, 5 bearish.
  • POCI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NEPH is a better buy in the short-term than POCI.

Price Growth

NEPH (@Pharmaceuticals: Other) experienced а +2.68% price change this week, while POCI (@Pharmaceuticals: Other) price change was -4.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.00%. For the same industry, the average monthly price growth was +4.49%, and the average quarterly price growth was +17.53%.

Reported Earning Dates

NEPH is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEPH($40.6M) has a higher market cap than POCI($34.3M). NEPH YTD gains are higher at: 160.544 vs. POCI (-7.158). NEPH has higher annual earnings (EBITDA): 1.49M vs. POCI (-5.34M). NEPH has more cash in the bank: 5.07M vs. POCI (2.55M). NEPH has less debt than POCI: NEPH (1.24M) vs POCI (2.11M). POCI has higher revenues than NEPH: POCI (17.6M) vs NEPH (16.7M).
NEPHPOCINEPH / POCI
Capitalization40.6M34.3M118%
EBITDA1.49M-5.34M-28%
Gain YTD160.544-7.158-2,243%
P/E Ratio31.92N/A-
Revenue16.7M17.6M95%
Total Cash5.07M2.55M199%
Total Debt1.24M2.11M59%
FUNDAMENTALS RATINGS
NEPH vs POCI: Fundamental Ratings
NEPH
POCI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
5498
PRICE GROWTH RATING
1..100
3677
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEPH's Valuation (66) in the null industry is in the same range as POCI (84). This means that NEPH’s stock grew similarly to POCI’s over the last 12 months.

POCI's Profit vs Risk Rating (85) in the null industry is in the same range as NEPH (100). This means that POCI’s stock grew similarly to NEPH’s over the last 12 months.

NEPH's SMR Rating (54) in the null industry is somewhat better than the same rating for POCI (98). This means that NEPH’s stock grew somewhat faster than POCI’s over the last 12 months.

NEPH's Price Growth Rating (36) in the null industry is somewhat better than the same rating for POCI (77). This means that NEPH’s stock grew somewhat faster than POCI’s over the last 12 months.

POCI's P/E Growth Rating (4) in the null industry is significantly better than the same rating for NEPH (100). This means that POCI’s stock grew significantly faster than NEPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEPHPOCI
RSI
ODDS (%)
Bearish Trend 4 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
75%
Bullish Trend 20 days ago
62%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EAF9.920.68
+7.36%
GrafTech International Ltd
AEIS153.743.60
+2.40%
Advanced Energy Industries
ALX234.464.36
+1.89%
Alexander's
DYCQ11.50N/A
N/A
DT Cloud Acquisition Corp
DASH246.85-1.93
-0.78%
DoorDash

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with IMDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then IMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
-4.13%
IMDX - NEPH
34%
Loosely correlated
+0.40%
SGHT - NEPH
33%
Loosely correlated
-1.07%
NEO - NEPH
25%
Poorly correlated
-0.99%
OFIX - NEPH
22%
Poorly correlated
-1.02%
VNRX - NEPH
22%
Poorly correlated
-5.18%
More

POCI and

Correlation & Price change

A.I.dvisor tells us that POCI and MLSS have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POCI and MLSS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POCI
1D Price
Change %
POCI100%
-2.52%
MLSS - POCI
22%
Poorly correlated
-0.55%
NEPH - POCI
22%
Poorly correlated
-4.13%
STXS - POCI
20%
Poorly correlated
+5.07%
BJDX - POCI
20%
Poorly correlated
+2.84%
RPID - POCI
20%
Poorly correlated
+11.48%
More